NeuroPace, Inc. has grown revenue 22% a year over three years and 16% a year over five. Revenue growth, 3-year annual rate: +22% (Medical Devices median +12%). Revenue growth, 5-year rate: +16%, growth has picked up over the last three years. Years of annual history on file: 6, FY2020 to FY2025, as filed.

NPCENeuroPace, Inc.

Healthcare

$12.37+16% 1Y

$12.37

$9.4052 weeks$19.29

Is it growing?

Good

Growing: revenue growing +17% year on year and operating margin widening (+9.5 points).

2 good, 1 without data

Revenue trend+17% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +16% a year.

Margin direction+9.5 points operating

Trailing-twelve-month operating margin, -16.0% now against -25.5% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is NPCE growing?

NeuroPace, Inc. has grown revenue 22% a year over three years and 16% a year over five.

+22%

Revenue growth, 3-year annual rate · Medical Devices median +12% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +16%
Revenue growth, 5-year rate · +22% over three · growth has picked up over the last three years
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›